Replies to post #2402 on SurModics Inc (SRDX)

[foolishpremise]

Ouch...nice catch.

[DewDiligence]

Is SRDX still working on a long-acting formulation of Lucentis? If so, readers may be interested in the results of the CATT study reported today:

#msg-62547005 Data
#msg-62550310 Musings on commercial significance for Roche/NVS
#msg-62552160 NEJM editorial
#msg-62552160 Musings on dosing frequency

Regards, Dew